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Abstract
Background: Proteomic techniques allow researchers to perform detailed analyses of cellular states and many
studies are published each year, which highlight large numbers of proteins quantified in different samples.
However, currently few data sets make it into public databases with sufficient metadata to allow other groups to
verify findings, perform data mining or integrate different data sets. The Proteomics Standards Initiative has
released a series of “Minimum Information About a Proteomics Experiment” guideline documents (MIAPE modules)
and accompanying data exchange formats. This article focuses on proteomic studies based on gel electrophoresis
and demonstrates how the corresponding MIAPE modules can be fulfilled and data deposited in public databases,
using a new experimental data set as an example.
Findings: We have performed a study of the effects of an anabolic agent (salbutamol) at two different time points
on the protein complement of rat skeletal muscle cells, quantified by difference gel electrophoresis. In the DIGE
study, a total of 31 non-redundant proteins were identified as being potentially modulated at 24 h post treatment
and 110 non redundant proteins at 96 h post-treatment. Several categories of function have been highlighted as
strongly enriched, providing candidate proteins for further study. We also use the study as an example of best
practice for data deposition.
Conclusions: We have deposited all data sets from this study in public databases for further analysis by the
community. We also describe more generally how gel-based protein identification data sets can now be deposited
in the PRoteomics IDEntifications database (PRIDE), using a new software tool, the PRIDESpotMapper, which we
developed to work in conjunction with the PRIDE Converter application. We also demonstrate how the ProteoRed
MIAPE generator tool can be used to create and share a complete and compliant set of MIAPE reports for this
experiment and others.
Introduction
A variety of high-throughput experimental techniques are
available for studying how the protein complement of a
sample (the proteome) changes under different cellular
conditions, such as during disease processes. The changes
observed in individual proteins, or groups of proteins, as
experimental conditions vary allow researchers to begin
understanding the underlying molecular mechanisms in
the cell. Gel electrophoresis (GE) has been employed to
study proteins for over four decades [1]. GE is frequently
applied in two dimensions, whereby proteins are separated
by charge followed by molecular weight [2]. More recently,
the difference in-gel electrophoresis technique (DIGE) [3]
has improved the relative quantification of proteins on
2-D gels. In DIGE, the whole proteomes of different sam-
ples are labelled with different fluorescent dyes, mixed and
applied to a single gel, thus reducing gel to gel variability
in protein migration. Despite the relative age of gel-based
proteomic techniques, and recent advances in liquid chro-
matography-mass spectrometry (LC-MS) for protein
quantification, gel-based techniques are still commonly
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used. For all proteomic techniques, it has been widely
documented that the protocols employed can influence
the results, for example introducing variability in the set of
proteins detected or the estimation of their individual
abundances. It is thus important to capture and report a
detailed set of information (termed metadata) about how
experiments were performed and analysed to allow groups
to verify findings, employ similar protocols in their own
labs or compare data sets generated in different
experiments.
The Human Proteome Organisation - Proteomics
Standards Initiative (HUPO-PSI, [4]) was created to help
scientists share their data, deposit data sets in public
databases and provide tools to assist other groups in
performing large scale analysis of public proteomic data
sets. In 2007, the PSI published the Minimum Informa-
tion About a Proteomics Experiment (MIAPE) specifica-
tion [5]. From this root document, a set of MIAPE
modules for proteomics techniques were delivered: gel
electrophoresis [6], gel image informatics [7], mass spec-
trometry [8], mass spectrometry informatics [9], column
chromatography [10], capillary electrophoresis [11] and
protein-protein or molecular interactions [12]. Each
MIAPE module contains a minimal checklist of items
that should be reported for the given technique. The
items can be reported using plain language, for example
describing specific points within the experimental proto-
cols or the data analysis that has been performed, to
allow other groups to interpret the published results
without ambiguity as to how they were generated. The
PSI has also developed data exchange formats, typically
represented in Extensible Markup Language (XML).
One of these, GelML [13], captures the data related to
gel electrophoresis experiments. There are a number of
public databases storing protein identification data from
proteomics, including PRIDE [14], PeptideAtlas [15],
Peptidome [16], the GPMDB [17] and the Swiss2D-
PAGE database storing GE experiments [18]. However
the widely used protein identification repositories
(PRIDE, PeptideAtlas etc) are primarily focussed on LC-
MS studies and historically have either no GE data sets
or no simple mechanism for deposition of data derived
from gel-based experiments.
In this article we demonstrate how MIAPE GE (gel
electrophoresis) and GI (gel informatics) compliant
reports can be created easily in practice, through the
MIAPE Generator tool [19], developed by ProteoRed -
the Spanish network for proteomics. We have also
developed a new tool, the PRIDESpotMapper, to work
alongside the PRIDE Converter software [20] to enable
GE studies to be captured in the PRIDE XML format
and be submitted to the public PRIDE repository. The
provision of both the MIAPE report and the public
PRIDE record, enables other groups to download the
complete data sets, including raw gel images, mass spec-
tra and protein identifications, along with complete
descriptions of the experimental protocols.
We have performed a study on the effects of salbuta-
mol (an anabolic agent) on the proteome of rat muscle
cells. Salbutamol is a type of beta2 adrenergic agonist,
which is known to cause hypertrophy in muscle but the
underlying molecular mechanisms are not well under-
stood. The aims of the study are to use proteomic tech-
nologies to model changes in the development of
skeletal muscle cells in vitro in the presence of salbuta-
mol and to identify novel proteins and pathways within
these cells that interact with these agents, and therefore
could be potential targets for their action. DIGE was
used to compare control and treated samples at 24 h
and 96 h after addition of salbutamol. Gel spots with
changed abundance were subjected to tandem mass
spectrometry for protein identification. Bioinformatics
analysis was performed using the Gene Ontology (GO)
[21] and the DAVID tool [22] for determining categories
of functions that appear to be enriched at the different
time points.
In the supplementary material [Additional file 1], we
include the protocols employed in the DIGE study, as
they would be reported in a standard journal article. We
have also used the ProteoRed MIAPE Generator to cre-
ate MIAPE GE and GI compliant reports (described in
[19]) and we use these examples to demonstrate how a
standard set of materials and methods map into the
MIAPE reports generated, to act as a practical guide to
MIAPE for proteome scientists. We have also deposited
the MS data sets and identifications in PRIDE, using the
PRIDESpotMapper and PRIDE Converter, for public
access and review.
Software development
The PRIDE Converter software [20] enables conversion
from a variety of mass spectra and search engine file
formats into the PRIDE XML format that can subse-
quently be used for uploading spectra and peptide/pro-
tein identifications into the PRIDE database. However,
the PRIDE Converter has been designed primarily for
“shotgun proteomics” experimental designs, where pep-
tide to protein inference is performed across all input
spectra, which is not well suited to gel-based studies.
The software is capable of loading multiple identifica-
tion files (e.g. Mascot dat files or Sequest .out files), but
in its internal processing, the resulting proteins are
inferred from a combined list containing all the identi-
fied peptides. For gel-based studies, typically each identi-
fication file (say one Mascot dat file) comes from a
single gel spot and its identified peptides should not be
combined with those from other spots. The PRIDE Con-
verter also has no mechanism for uploading gel image
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coordinates, or additional information regarding protein
quantification. To overcome these limitations, a custom
version of the PRIDE Converter was developed by the
PRIDE team, where every identified peptide was anno-
tated with the name of the source gel spot. Simulta-
neously, we developed a new application called “the
PRIDESpotMapper” as a complement to the PRIDE
Converter for gel-based experiments. This was imple-
mented in Java and modifies the PRIDE XML file gener-
ated using the custom PRIDE Converter, dividing the
identified proteins according to the source identification
file for each gel spot. Starting from a PRIDE XML file
and either an XML or Excel spot map (see [Additional
File 2] for the format specifications) the application
ensures that records are created for each identified pro-
tein, derived from peptide identifications from each
input file independently.
Once all the resulting files coming from the search
engine (Mascot for this version) are joined in a single
PRIDE XML using the PRIDE Converter, the execution
of the PRIDESpotMapper is straightforward (Figure 1).
First, either the XML or Excel spot map file should be
entered. Second, the gel image can be loaded from a
local file or from a URI, for example if gel images have
been loaded into the ProteoRed MIAPE Generator data-
base [19]. Third, the previously created PRIDE XML file
is required. The application merges the two data files
(Spot map file and PRIDE XML file) to create a new
PRIDE XML file (internally called 2D PRIDE XML file),
in which each spot is linked to one protein only with its
corresponding peptides, alongside gel spot coordinates
and relative quantification data. The file is then saved
on the local drive, ready for upload to the PRIDE
database.
Results
The DIGE gels were analyzed as described in the Sup-
plementary Methods [Additional file 1] and sets of spots
were identified as being differentially expressed at the
24 h time point (versus the untreated control) and 96 h
time point (versus control). The protein(s) contained
within those spots were then identified by tandem mass
spectrometry (MS/MS). In most spots, more than one
protein was identified, indicating that some co-migration
of proteins occurred (and the high sensitivity of MS/
MS). As such it is not always possible to link exact
quantitative differences between conditions to specific
proteins, although general conclusions can be made
about the groups of proteins that have changed between
conditions. The proteins that were identified with high
confidence were further analyzed using the DAVID tool
[22], which highlighted several functions that were
strongly enriched (discussed below).
At the 24 h time point 17 spots of interest were identi-
fied: 4 spots were down-regulated, 13 spots up-regulated
from which 31 non-redundant proteins were identified
[Additional file 3]. 23% of the proteins identified are
cytoskeletal and also are mapped in pathways involved
with skeletal development (based on Gene Ontology
terms). At the 96 h time point 35 spots of interest were
identified - 11 spots were down-regulated, 24 spots up-
regulated [Additional file 4]. From these spots 110 non-
redundant proteins were identified. 25% of these proteins
are cytoskeletal proteins. Several of these proteins, e.g.
vimentin and desmin, are known to be involved in the
skeletal development pathway. There are several proteins
modulated in both sample sets, such as beta-enolase that
is involved in glycolysis. Some proteins were found in
more than one spot, which could suggest the presence of
post-translational modifications, such as phosphorylation.
We have performed gene ontology enrichment analy-
sis on the two data sets using DAVID (24 h [Additional
file 5] and 96 h [Additional file 6]). At 24 h the main
functional clusters enriched were: “contractile fiber”,
“cytoskeleton”, “calcium ion binding” and “collagen bio-
synthetic process”. At 96 h post treatment, the main
enriched functional categories were “cytoskeleton”,
“tubulin”, “microtubule-based movement”, “GTPase
activity” “cellular protein complex assembly”, “contrac-
tile fiber” and “regulation of ATPase activity” amongst
several others.
In summary, proteins involved in ion binding and
transport, nucleosome assembly, cell interactions,
Mass spectra files 
and identifications
PRIDE Converter
PRIDE XML File
CSV Mapping File
(contains spot coordinates and 
links to protein identification files)
PRIDESpotMapper
2D PRIDE XML File
Figure 1 The workflow used to construct a PRIDE XML file
containing gel spot data, via the modified PRIDE Converter
and the PRIDESpotMapper.
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protein binding and structural proteins seem to be
modulated at 96 h, whereas only structural and energy
production proteins are affected after 24 h. An immedi-
ate effect of the anabolic agent is to produce a structural
effect that needs a great deal of energy. It appears a
more complex later effect is observed, involving a num-
ber of cellular pathways.
Salbutamol is shown to cause muscle hypertrophy,
which suggests it may have a similar mode of action as
other beta2-adrenergic agonists. This effect on the muscle
cell is rapid, and is clearly seen using high magnification
microscopy. As anticipated, many of the differentially
expressed proteins identified are cytoskeletal. A signifi-
cant number are also involved in transcription or transla-
tion. Skeletal development pathways are activated both at
the early and later time points. Up-regulation of ATP
synthesis, glycolysis and phosphorylation also seems to
be occurring.
Data deposition and MIAPE report generation
MIAPE guideline documents describe the metadata that
should be captured about a given proteomic technique,
for instance detailing the minimum information that
should be reported about the experimental protocols.
The MIAPE Generator tool has been developed to assist
in the generation of MIAPE-compliant reports, and is
freely accessible from http://www.proteored.org/. The
tool guides users through each stage of the report crea-
tion process, capturing all details required by the under-
lying MIAPE module. The tool’s user interface is based
on a series of web forms for data entry, built on top of
a relational database. These forms follow a hierarchical
structure according to the original sections of each
MIAPE module. Each document is always linked to a
project, which can be viewed and accessed only by the
project owner, until the document is ready for public
access. The tool has a template system such that proto-
cols can be re-used in different reports to avoid repeti-
tion in data entry, and drop-down boxes are provided as
applicable, containing controlled vocabulary or ontology
terms to capture standard terminology for techniques,
units and so on, to allow reports to be compared auto-
matically. The generated reports are stored in the data-
base and can be exported in a variety of formats. In this
instance, the MIAPE Generator tool was used to create
two reports for each time point, capturing the methods
detailed above concerning gel electrophoresis sections
(in the MIAPE GE report) and concerning the gel image
informatics sections (in the MIAPE GI report) - see
“Availability and requirements”.
The benefits of producing the MIAPE reports, in addi-
tion or instead of a traditional Materials and Methods,
are as follows. The report has a standard structure,
requesting key details for each stage of the process,
ensuring that the experimenter does not fail to report
any information that may be important for reproducing
the protocols in another lab. As one example, the
MIAPE GE document requests that the gel recipe are
provided (section 3.2.2) if the gel was not purchased
pre-cast. Similarly, the MIAPE GI document requests
details should be provided on software parameters and
algorithms used with different software packages, which
can affect the results obtained. The MIAPE GE/GI spe-
cifications also request that raw data should be provided
and linked to the report, in this case, the original gel
images. This could potentially be hugely valuable if
researchers are interested in performing more detailed
examination of results, for example to test if a specific
protein is differentially regulated, using different statisti-
cal assumptions than the researchers who generated the
data.
Deposition of protein identification data in PRIDE
The PRIDE database has become one of the leading
public repositories for proteomics results. However, to
date, few gel studies have been deposited in PRIDE due
to the lack of appropriate tools. We have deposited two
files - one for the 24 h and one for 96 h time point,
each containing the protein identifications for each gel
spot. Each protein identification has a link to the gel
image in the MIAPE database, along with X/Y coordi-
nates and quantification information, in terms of the
ratio detected by DIGE across treated versus control
samples. As far as we are aware, this is the first deposi-
tion of a complete quantitative DIGE data set in PRIDE.
The PRIDE records can be accessed at http://www.ebi.
ac.uk/pride/ under accessions 16472 and 16473. Data
files download from PRIDE can be visualised using the
PRIDEViewer software [23].
Discussion and Conclusions
Each year there are many hundreds of proteomics stu-
dies published in the literature, in which gel electro-
phoresis is used to separate, identify and perform
relative quantification of the proteins present in com-
plex samples. However, few of these data sets have ever
made it into the public domain, beyond lists of protein
spots provided in tables within articles or as supplemen-
tary material in spreadsheets. The Proteomics Standards
Initiative has released several tools and guideline docu-
ments designed to improve the public accessibility of
proteomics data, including minimum reporting guide-
lines (MIAPE documents) and XML formats. The EBI
has also developed the PRIDE database to allow proteo-
mics scientists to publish protein identification data sets
to the wider community.
While it is possible to include protein identification
data in the database behind the MIAPE generator tool,
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this is not the standard public repository for this kind of
data. Instead, proteomics scientists tend to search the
PRIDE database (or GPM, PeptideAtlas, Peptidome,
Tranche) for identification data. As such, it is important
for gel-based proteomics studies to be deposited in one
of these primary data repositories. To date, almost no
data sets derived from gel-based experiments have been
deposited in any of these databases. We have created
the PRIDESpotMapper to work alongside the PRIDE
Converter and thus, for the first time, provide a simple
route for uploading valid PRIDE XML, containing gel
spot information and quantitative values. The PRIDE
developers may include gel support in future versions of
the PRIDE Converter directly. We will work with the
PRIDE team to incorporate the same mechanism pre-
sented here for representing gel spot data, to ensure
that researchers wishing to share gel-based proteomic
data can use the PRIDESpotMapper now, and migrate
to a new version of the PRIDE Converter, as and when
appropriate.
This article should serve as an exemplar for how
researchers can upload gel-based data to PRIDE and use
the MIAPE Generator tool for creating MIAPE compli-
ant reports. There is on-going discussion with journal
editors as to the requirement for proteomics articles to
be MIAPE compliant - and these reports may in due
course supplement, or in some cases replace, traditional
materials and methods sections of proteomics articles.
We encourage further discussion of these issues, for
example through the PSI’s open mailing lists or atten-
dance at the annual PSI meeting.
For the study described, we have created MIAPE
reports describing the gel electrophoresis and the gel
image informatics performed, and these have been
deposited in the associated database. The database also
contains the source gel images, allowing other groups to
re-analyse these data, using the same or different soft-
ware pipelines.
The initial results of the study show that several key
pathways are modulated by treatment with salbutamol,
with significantly more changes occurring at 96 h post-
treatment. This indicates that there is a lag between the
treatment and the downstream activation of cellular
pathways. There are some limitations of the DIGE
results, not least that true quantitative ratios cannot be
linked to individual protein identities, since the sensitiv-
ity of tandem MS revealed that many spots on the gels
contained more than one protein. However, the ontol-
ogy enrichment analysis shows that many of the protein
groups highlighted are likely to be direct or indirect tar-
gets for salbutamol, since the enriched functional cate-
gories fit our expected hypotheses of the effects of an
adrenergic agonist. We are making these data sets freely
available as we anticipate that they will be useful to
other researchers working in this area for building
hypotheses about the mechanism of action of salbuta-
mol on the proteome of muscle tissue.
Availability and requirements
The software described in this article is accessible from
http://proteo.cnb.csic.es/pridespotmapper.
The adapted PRIDE Converter described here is
released as a snapshot build (2.4.2), which will be
updated periodically when there are major new releases
of the main PRIDE Converter software but not for
minor updates. The PRIDE Converter is freely available
and open-source, released under Apache License 2.0.
PRIDE Converter requires Java 1.5 (or above). The cur-
rent version has been tested on Windows XP, Windows
Vista, Linux and Mac OS X.
The PRIDESpotMapper is freely available as a Java jar
file for local install or can be run using Java web start.
The application has tested using Java Runtime Environ-
ment (JRE) 1.6 with the following operating systems:
Windows 7, Windows XP, Windows Vista, Linux Red
Hat, Linux Ubuntu.
URLs to link direct to these records in the MIAPE
Generator database.
24 h timepoint:
http://estrellapolar.cnb.csic.es/proteored/MIAPE/MIA-
PE_GE.asp?pmCodigoAcceso=415db6c1&pmIDUsuario=
2378&pmId=1082
http://estrellapolar.cnb.csic.es/proteored/MIAPE/MIA
PE_GI.asp?pmCodigoAcceso=1d9f04d3&pmIDUsuario=
2378&pmId=768
96 h timepoint:
http://estrellapolar.cnb.csic.es/proteored/MIAPE/MIA-
PE_GE.asp?pmCodigoAcceso=ae31268d&pmIDUsuario=
2378&pmId=663
http://estrellapolar.cnb.csic.es/proteored/MIAPE/MIA-
PE_GI.asp?pmCodigoAcceso=a43637ec&pmIDUsuario=
2378&pmId=397
PRIDE access for data sets
Accessions 16472 and 16473
Mascot dat files located on Tranche:
24 h time point:
https://proteomecommons.org/dataset.jsp?id=ziJZ-
S3iGNcd5eMDW3vPpCb5VXJ4oorFWe1xwdIaE97-
hUxDNcXwtXaf6twotWtsTds4RVu84Obfg-
w2oLp3k7tRjWXWx8AAAAAAAAChw%3D%3D
96 h time point:
https://proteomecommons.org/dataset.jsp?id=bZv347-
BIF4uVOWlwKok4ASHz2OCgPSXwqxfNP4LB2Qqna6-
tEnYVQNilPsrlQMgIAZBUAxyJCBpCK2kRqq%2BPCo-
QIv6oAAAAAAAAACjg%3D%3D
Passphrase: ratproteome
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Additional material
Additional file 1: Supplementary Methods. The materials and methods
from this study
Additional file 2: Example mapping file for the PRIDESpotMapper.
The csv file can be opened, for example, in spreadsheet software. The file
contains information for mapping Mascot dat files to spot coordinates
on gel images, and is used to create the final PRIDE XML file.
Additional file 3: Proteins with changed abundance at 24 h post-
treatment. A summary file containing the set of proteins that had
modulated abundance, as detected by DIGE, at 24 h post-treatment with
salbutamol.
Additional file 4: Proteins with changed abundance at 96 h post-
treatment. A summary file containing the set of proteins that had
modulated abundance, as detected by DIGE, at 96 h post-treatment with
salbutamol.
Additional file 5: Clusters of functional annotations for proteins at
24 h post-treatment. The output of clustering functional annotations
produced by DAVID, on the protein set at 24 h post-treatment
Additional file 6: Clusters of functional annotations for proteins at
96 h post-treatment. The output of clustering functional annotations
produced by DAVID, on the protein set at 96 h post-treatment
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